Vaccine compositions
US10980871B2 · kind B2 · utility
1Cited by
23References
17Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 8, 2018 |
| Grant date | Apr 20, 2021 |
| Priority date | — |
| Expiry date | May 8, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2760/16251
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to an immunogenic composition comprising influenza virus antigens derived from at least 5 influenza virus strains and one or more compounds of formula (I) or physiologically acceptable salts or esters thereof: wherein: R1 represents hydrogen or C1-6 alkyl; R2 represents C1-6 alkyl; and R3 represents C1-6 alkyl. The invention also relates to methods of preparing the immunogenic composition, to pharmaceutical and vaccine compositions comprising the immunogenic composition and to use of the immunogenic, pharmaceutical and vaccine compositions for preventing influenza virus infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.